I was scanning back through the 4C from last October and I noted that the company stated that at that stage they were 12-18 months away from commercial release for Angelmed.
Given that the SP has been on a rollercoaster ride in the past month and some of us have been left high and dry including myself it got me thinking .
I wanted to ask LT holders here whether they think the company is -
A: Meeting it's objectives, as it states in its 4Cs
B: Reaching a turning point due to positive operating cash flow
C: considering the 50m + aggregate pipeline as stated are we anticipating some big inflows of positive news and a short to medium term rerate ?
Even just looking at today's Ann it shows that Hdyrix is intricately involved in the MEM device and they are on the cutting edge of the design side of these products.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.091M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 333444 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.21pm 11/09/2025 (20 minute delay) ? |
| HYD (ASX) Chart |
Day chart unavailable